Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harrow Inc (NQ: HROW ) 39.48 +0.56 (+1.44%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Harrow Inc < Previous 1 2 3 4 5 6 7 Next > Home Depot, Beauty Health And 3 Stocks To Watch Heading Into Tuesday November 14, 2023 With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 13, 2023 Via Benzinga Recap: Harrow Q3 Earnings November 13, 2023 Via Benzinga Harrow Announces Third Quarter 2023 Financial Results November 13, 2023 From Harrow, Inc. Via Business Wire Harrow Health's Earnings Outlook November 10, 2023 Via Benzinga Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/30 May 30, 2023 Via Investor Brand Network Earnings Scheduled For November 13, 2023 November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023 October 30, 2023 From Harrow, Inc. Via Business Wire Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S. October 24, 2023 From Harrow, Inc. Via Business Wire Harrow Health, Inc. Changes Corporate Name to Harrow, Inc. September 29, 2023 From Harrow Health, Inc. Via Business Wire Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation September 26, 2023 From Melt Pharmaceuticals, Inc. Via Business Wire Harrow Announces Second Quarter 2023 Financial Results August 09, 2023 From Harrow Health, Inc. Via Business Wire Harrow Launches VIGAMOX® in the U.S. July 31, 2023 From Harrow Health, Inc. Via Business Wire Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023 July 26, 2023 From Harrow Health, Inc. Via Business Wire Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected July 19, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also... Via Benzinga Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 19, 2023 Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session July 19, 2023 Via Benzinga Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results July 19, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,... Via Benzinga Why Shares of Harrow Health Are Jumping Wednesday July 19, 2023 The company increased guidance, acquired a company, and had a stock sale. Via The Motley Fool Why Harrow Health Stock Is Trading Higher Today? July 19, 2023 Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH. Via Benzinga AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday July 19, 2023 U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Harrow Prices $60 Million Public Offering of Common Stock July 19, 2023 From Harrow Health, Inc. Via Business Wire Harrow Acquires Santen’s Branded Ophthalmic Portfolio July 18, 2023 From Harrow Health, Inc. Via Business Wire Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance July 18, 2023 From Harrow Health, Inc. Via Business Wire Harrow Announces Proposed Public Offering of Common Stock July 18, 2023 From Harrow Health, Inc. Via Business Wire Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq July 18, 2023 From Harrow Health, Inc. Via Business Wire Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023 May 17, 2023 From Harrow Via Business Wire NASDAQ:HROW Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties at Harrow Health, Inc May 16, 2023 San Diego, CA -- (SBWIRE) -- 05/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Harrow Health, Inc. Via SBWire Why Shares of Harrow Health Are Slumping Friday May 12, 2023 The pharmaceutical company announced first-quarter earnings Thursday afternoon. Via The Motley Fool Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 12, 2023 Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.